Toward robust proton therapy planning and delivery

Translational Cancer Research

Volumn 1, Issue 3, 2012, Pages 217-226

  Li, Zuofeng ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84962682525     PISSN: 2218676X     EISSN: 22196803     Source Type: Journal    
DOI: 10.3978/j.issn.2218-676X.2012.10.01     Document Type: Review

References (56)

1. Schneider U, Pedroni E, Lomax A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys Med Biol 1996;41:111-24.
2. Yohannes I, Kolditz D, Langner O, et al. A formulation of tissue-and water-equivalent materials using the stoichiometric analysis method for CT-number calibration in radiotherapy treatment planning. Phys Med Biol 2012;57:1173-90.
3. Schaffner B, Pedroni E. The precision of proton range calculations in proton radiotherapy treatment planning: experimental verification of the relation between CT-HU and proton stopping power. Phys Med Biol 1998;43:1579-92.
4. Moyers MF, Miller DW, Bush DA, et al. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys 2001;49:1429-38.
5. Yang M, Zhu XR, Park PC, et al. Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol 2012;57:4095-115.
6. Chang JY, Komaki R, Wen HY, et al. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011;80:1350-7.
7. Albertini F, Hug EB, Lomax AJ. Is it necessary to plan with safety margins for actively scanned proton therapy? Phys Med Biol 2011;56:4399-413.
8. Lomax AJ, Boehringer T, Coray A, et al. Intensity modulated proton therapy: a clinical example. Med Phys 2001;28:317-24.
9. Inaniwa T, Kanematsu N, Furukawa T, et al. A robust algorithm of intensity modulated proton therapy for critical tissue sparing and target coverage. Phys Med Biol 2011;56:4749-70.
10. Liu W, Zhang X, Li Y, et al. Robust optimization of intensity modulated proton therapy. Med Phys 2012;39:1079-91.
11. International Commission on Radiation Units and Measurements. ICRU Report 78: Prescribing, recording, and reporting proton-beam therapy. J ICRU 2007;7:210.
12. Hong L, Goitein M, Bucciolini M, et al. A pencil beam algorithm for proton dose calculations. Phys Med Biol 1996;41:1305-30.
13. Schaffner B, Pedroni E, Lomax A. Dose calculation models for proton treatment planning using a dynamic beam delivery system: an attempt to include density heterogeneity effects in the analytical dose calculation. Phys Med Biol 1999;44:27-41.
14. Wagner MS. Automated range compensation for proton therapy. Med Phys 1982;9:749-52.
15. Urie M, Goitein M, Wagner M. Compensating for heterogeneities in proton radiation therapy. Phys Med Biol 1984;29:553-66.
16. Li G. Experimental comparison of range compensator calculation algorithms and milling strategies. 51st Particle Therapy Collaborative Group Annual Meeting 2012.
17. Hugo G, Vargas C, Liang J, et al. Changes in the respiratory pattern during radiotherapy for cancer in the lung. Radiother Oncol 2006;78:326-31.
18. Trofimov A, Nguyen PL, Efstathiou JA, et al. Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2011;80:928-37.
19. Kang Y, Zhang X, Chang JY, et al. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys 2007;67:906-14.
20. Engelsman M, Rietzel E, Kooy HM. Four-dimensional proton treatment planning for lung tumors. Int J Radiat Oncol Biol Phys 2006;64:1589-95.
21. Engelsman M, Kooy HM. Target volume dose considerations in proton beam treatment planning for lung tumors. Med Phys 2005;32:3549-57.
22. Bert C, Rietzel E. 4D treatment planning for scanned ion beams. Radiat Oncol 2007;2:24.
23. Knopf A, Bert C, Heath E, et al. Special report: workshop on 4D-treatment planning in actively scanned particle therapy-recommendations, technical challenges, and future research directions. Med Phys 2010;37:4608-14.
24. Morávek Z, Rickhey M, Hartmann M, et al. Uncertainty reduction in intensity modulated proton therapy by inverse Monte Carlo treatment planning. Phys Med Biol 2009;54:4803-19.
25. Shirato H, Onimaru R, Ishikawa M, et al. Real-time 4-D radiotherapy for lung cancer. Cancer Sci 2012;103:1-6.
26. Unkelbach J, Bortfeld T, Martin BC, et al. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. Med Phys 2009;36:149-63.
27. Park PC, Zhu XR, Lee AK, et al. A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties. Int J Radiat Oncol Biol Phys 2012;82:e329-36.
28. Chang JY, Cox JD. Improving radiation conformality in the treatment of non-small cell lung cancer. Semin Radiat Oncol 2010;20:171-7.
29. Bert C, Durante M. Motion in radiotherapy: particle therapy. Phys Med Biol 2011;56:R113-44.
30. Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008;53:1043-56.
31. Yu CX, Jaffray DA, Wong JW. The effects of intra-fraction organ motion on the delivery of dynamic intensity modulation. Phys Med Biol 1998;43:91-104.
32. Kraus KM, Heath E, Oelfke U. Dosimetric consequences of tumour motion due to respiration for a scanned proton beam. Phys Med Biol 2011;56:6563-81.
33. Seco J, Robertson D, Trofimov A, et al. Breathing interplay effects during proton beam scanning: simulation and statistical analysis. Phys Med Biol 2009;54:N283-94.
34. Zhang Y, Boye D, Tanner C, et al. Respiratory liver motion estimation and its effect on scanned proton beam therapy. Phys Med Biol 2012;57:1779-95.
35. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006;33:3874-900.
36. Zenklusen SM, Pedroni E, Meer D. A study on repainting strategies for treating moderately moving targets with proton pencil beam scanning at the new Gantry 2 at PSI. Phys Med Biol 2010;55:5103-21.
37. Barker JL Jr, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004;59:960-70.
38. Shi W, Nichols RC, Flampouri S, et al. Tumour shrinkage during proton-based chemoradiation for non-small-cell lung cancer may necessitate adaptive replanning during treatment. Hong Kong J Radiol 2011;14:190-4.
39. Shi W, Nichols RC, Flampouri S, et al. Proton-based chemoradiation for synchronous bilateral non-small-cell lung cancers: a case report. Thoracic Cancer 2012. [Epub ahead of print].
40. Hui Z, Zhang X, Starkschall G, et al. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys 2008;72:1385-95.
41. Koay EJ, Lege D, Mohan R, et al. Adaptive/Nonadaptive Proton Radiation Planning and Outcomes in a Phase II Trial for Locally Advanced Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2012. [Epub ahead of print].
42. Beltran C, Naik M, Merchant TE. Dosimetric effect of target expansion and setup uncertainty during radiation therapy in pediatric craniopharyngioma. Radiother Oncol 2010;97:399-403.
43. Beltran C, Roca M, Merchant TE. On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 2012;82:e281-7.
44. Albertini F, Bolsi A, Lomax AJ, et al. Sensitivity of intensity modulated proton therapy plans to changes in patient weight. Radiother Oncol 2008;86:187-94.
45. Swanson EL, Indelicato DJ, Louis D, et al. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys 2012;83:1549-57.
46. Nichols RC Jr, Huh SN, Prado KL, et al. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer. Int J Radiat Oncol Biol Phys 2012;83:158-63.
47. Vargas C, Mahajan C, Fryer A, et al. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2007;69:1110-6.
48. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-21.
49. Paganetti H. Significance and implementation of RBE variations in proton beam therapy. Technol Cancer Res Treat 2003;2:413-26.
50. Wilkens JJ, Oelfke U. Optimization of radiobiological effects in intensity modulated proton therapy. Med Phys 2005;32:455-65.
51. Tilly N, Johansson J, Isacsson U, et al. The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer. Phys Med Biol 2005;50:2765-77.
52. Wambersie A, Hendry JH, Andreo P, et al. The RBE issues in ion-beam therapy: conclusions of a joint IAEA/ICRU working group regarding quantities and units. Radiat Prot Dosimetry 2006;122:463-70.
53. Jäkel O. The relative biological effectiveness of proton and ion beams. Z Med Phys 2008;18:276-85.
54. Frese MC, Wilkens JJ, Huber PE, et al. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy. Int J Radiat Oncol Biol Phys 2011;79:80-8.
55. Wambersie A, Menzel HG, Andreo P, et al. Isoeffective dose: a concept for biological weighting of absorbed dose in proton and heavier-ion therapies. Radiat Prot Dosimetry 2011;143:481-6.
56. Carabe A, Moteabbed M, Depauw N, et al. Range uncertainty in proton therapy due to variable biological effectiveness. Phys Med Biol 2012;57:1159-72.